Adult stem cell products could be lining up to penetrate the inflammation and orthopedics markets, judging by the recent $1.38 billion paid by Genzyme for Osiris's mesenchymal stem cell technology.
In September, Osiris, based in Columbia, Maryland, reported the third and fourth clinical trial failures in 12 months for its mesenchymal stem cell (MSC) therapy. These late failures were both in ...
The OSIRIS program aims to develop optical communications technology and systems for the direct downlink from and the direct connection between small satellites – such as those used in earth ...
"We really did kind of make a mess." That was Dante Lauretta's take after reviewing the first pictures to come down from Nasa's Osiris-Rex probe following its bid to grab a sample from asteroid ...
The samples had been scooped up from the surface of asteroid Bennu in 2020 by the Osiris-Rex spacecraft. Nasa wants to learn more about the mountainous object, not least because it has an outside ...